202 related articles for article (PubMed ID: 37391593)
1. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
[TBL] [Abstract][Full Text] [Related]
2. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26.
Liu N; Wu Z; Chen A; Wang Y; Cai D; Zheng J; Liu Y; Zhang L
Cell Death Dis; 2019 Sep; 10(9):667. PubMed ID: 31511502
[TBL] [Abstract][Full Text] [Related]
3. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
4. Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome.
Lynch DC; Revil T; Schwartzentruber J; Bhoj EJ; Innes AM; Lamont RE; Lemire EG; Chodirker BN; Taylor JP; Zackai EH; McLeod DR; Kirk EP; Hoover-Fong J; Fleming L; Savarirayan R; ; Majewski J; Jerome-Majewska LA; Parboosingh JS; Bernier FP
Nat Commun; 2014 Jul; 5():4483. PubMed ID: 25047197
[TBL] [Abstract][Full Text] [Related]
5. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.
Zhan YT; Li L; Zeng TT; Zhou NN; Guan XY; Li Y
Aging (Albany NY); 2020 Dec; 13(1):537-554. PubMed ID: 33289700
[TBL] [Abstract][Full Text] [Related]
6. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
7. Bypass of premature stop codons and generation of functional BRCA2 by exon skipping.
Stauffer S; Biswas K; Sharan SK
J Hum Genet; 2020 Sep; 65(9):805-809. PubMed ID: 32393813
[TBL] [Abstract][Full Text] [Related]
8. Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.
Liu X; Zhang J; Wang Z; Yan M; Xu M; Li G; Shender V; Wei JJ; Li J; Shao C; Zhang S; Kong B; Song K; Liu Z
Adv Sci (Weinh); 2024 Apr; 11(15):e2306229. PubMed ID: 38342602
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
[TBL] [Abstract][Full Text] [Related]
10. SNRPB promotes cervical cancer progression through repressing p53 expression.
Zhu L; Zhang X; Sun Z
Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
[TBL] [Abstract][Full Text] [Related]
11. c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
Peng N; Li J; He J; Shi X; Huang H; Mo Y; Ye H; Wu G; Wu F; Xiang B; Zhong J; Li L; Zhu S
Cell Biol Int; 2020 May; 44(5):1103-1111. PubMed ID: 31930637
[TBL] [Abstract][Full Text] [Related]
12. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?
Ware MD; DeSilva D; Sinilnikova OM; Stoppa-Lyonnet D; Tavtigian SV; Mazoyer S
Oncogene; 2006 Jan; 25(2):323-8. PubMed ID: 16170354
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
[TBL] [Abstract][Full Text] [Related]
14. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
[TBL] [Abstract][Full Text] [Related]
15. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
[TBL] [Abstract][Full Text] [Related]
16. SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer.
Liu N; Chen A; Feng N; Liu X; Zhang L
Med Oncol; 2021 Apr; 38(5):57. PubMed ID: 33835288
[TBL] [Abstract][Full Text] [Related]
17. Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome.
Bacrot S; Doyard M; Huber C; Alibeu O; Feldhahn N; Lehalle D; Lacombe D; Marlin S; Nitschke P; Petit F; Vazquez MP; Munnich A; Cormier-Daire V
Hum Mutat; 2015 Feb; 36(2):187-90. PubMed ID: 25504470
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.
Popli P; Richters MM; Chadchan SB; Kim TH; Tycksen E; Griffith O; Thaker PH; Griffith M; Kommagani R
Cell Death Dis; 2020 Oct; 11(10):842. PubMed ID: 33040078
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes.
Acedo A; Sanz DJ; Durán M; Infante M; Pérez-Cabornero L; Miner C; Velasco EA
Breast Cancer Res; 2012 May; 14(3):R87. PubMed ID: 22632462
[TBL] [Abstract][Full Text] [Related]
20. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
